CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: September 21, 2016
Result type: Reports
Project Number: SR0505-000
Product Line: Reimbursement Review

Generic Name: Liraglutide

Brand Name: Victoza

Manufacturer: Novo Nordisk Canada Inc.

Therapeutic Area: Diabetes Mellitus, Type 2

Indications: Diabetes Mellitus, Type 2

Submission Type: Resubmission

Project Status: Withdrawn